![Pharmacological Preconditioning of Mesenchymal Stem Cells with Trimetazidine (1-[2,3,4-Trimethoxybenzyl]piperazine) Protects Hypoxic Cells against Oxidative Stress and Enhances Recovery of Myocardial Function in Infarcted Heart through Bcl-2 Expression]()
Pharmacological Preconditioning of Mesenchymal Stem Cells with Trimetazidine (1-[2,3,4-Trimethoxybenzyl]piperazine) Protects Hypoxic Cells against Oxidative Stress and Enhances Recovery of Myocardial Function in Infarcted Heart through Bcl-2 ExpressionWisel, S.; Khan, M.; Kuppusamy, M. L.; Mohan, I. K.; Chacko, S. M.; Rivera, B. K.; Sun, B. C.; Hideg, K.; Kuppusamy, P. · Journal of Pharmacology and Experimental Therapeutics · 2009